Advancements in the study of DLK1 in the pathogenesis of diabetes

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Research

Background:

• Delta-like homolog 1 (DLK1) is a membrane-bound protein involved in developmental and metabolic processes.
• DLK1 functions as a ligand downstream of the Notch signaling pathway.
• Recent findings suggest DLK1's role in regulating insulin synthesis and secretion.

Purpose of the Study:

• To review the relationship between DLK1 and diabetes mellitus (DM).
• To summarize recent research advancements on DLK1 in metabolic diseases.
• To discuss future research directions and challenges in this field.

Main Methods:

• Literature review of studies investigating DLK1.
• Analysis of research on DLK1's role in insulin regulation.
• Examination of DLK1's involvement in metabolic pathways (ERK, AKT).

Main Results:

• DLK1 can induce insulin synthesis and secretion through the ERK and AKT signaling pathways.
• This mechanism implicates DLK1 in the pathogenesis of metabolic diseases.
• The connection between DLK1 and diabetes mellitus is an emerging area of research.

Conclusions:

• DLK1 plays a significant role in insulin regulation and metabolic homeostasis.
• Understanding the DLK1-diabetes axis is crucial for developing novel therapeutic strategies.
• Further investigation is warranted to fully elucidate DLK1's function and therapeutic potential in diabetes.